Pacira BioSciences (PCRX) Goodwill & Intangibles (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Goodwill & Intangibles of $373.0 million for Q1 2026, down 18.29% year-over-year from $456.5 million in Q1 2025, and down 3.94% quarter-over-quarter from $388.3 million in Q4 2025.
Pacira BioSciences (PCRX) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Pacira BioSciences' Goodwill & Intangibles history runs 17 years deep, the most recent figure standing at $373.0 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 18.29% year-over-year to $373.0 million; the TTM figure through Mar 2026 stood at $373.0 million (down 18.29% YoY), while the FY2025 annual figure was $388.3 million, down 8.84% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $373.0 million, down from $388.3 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $755.4 million in Q1 2022, with the low at $373.0 million in Q1 2026.
- The 5-year median for Goodwill & Intangibles is $632.2 million (2024), against an average of $575.9 million.
- The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles soared 289.26% in 2022, then plunged 34.11% in 2024.
- Pacira BioSciences' Goodwill & Intangibles stood at $703.7 million in 2022, then dropped by 8.13% to $646.5 million in 2023, then slumped by 34.11% to $426.0 million in 2024, then slipped by 8.84% to $388.3 million in 2025, then declined by 3.94% to $373.0 million in 2026.
- Business Quant data shows PCRX's Goodwill & Intangibles at $373.0 million in Q1 2026, $388.3 million in Q4 2025, and $402.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Pacira BioSciences | 948.08 Mn | 697.05 Mn | 148.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 305.13 Mn |
| Mar 31, 2026 | 373.00 Mn |
| Dec 31, 2025 | 388.30 Mn |
| Sep 30, 2025 | 402.71 Mn |
| Jun 30, 2025 | 442.86 Mn |
| Mar 31, 2025 | 456.49 Mn |
| Dec 31, 2024 | 425.97 Mn |
| Sep 30, 2024 | 440.29 Mn |
| Jun 30, 2024 | 617.81 Mn |
| Mar 31, 2024 | 632.18 Mn |
| Dec 31, 2023 | 646.50 Mn |
| Sep 30, 2023 | 660.82 Mn |
| Jun 30, 2023 | 675.15 Mn |
| Mar 31, 2023 | 689.47 Mn |
| Dec 31, 2022 | 703.75 Mn |
| Sep 30, 2022 | 738.40 Mn |
| Jun 30, 2022 | 741.46 Mn |
| Mar 31, 2022 | 755.37 Mn |
| Dec 31, 2021 | 769.17 Mn |
| Sep 30, 2021 | 190.17 Mn |